<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:28:45Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8291688" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8291688</identifier>
        <datestamp>2021-07-31</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" xml:lang="en" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8291688</article-id>
              <article-id pub-id-type="pmcid">PMC8291688</article-id>
              <article-id pub-id-type="pmc-uid">8291688</article-id>
              <article-id pub-id-type="pmid">34283841</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0253544</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-20-40261</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Parasitic Diseases</subject>
                      <subj-group>
                        <subject>Malaria</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Tropical Diseases</subject>
                      <subj-group>
                        <subject>Malaria</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Hematology</subject>
                    <subj-group>
                      <subject>Anemia</subject>
                      <subj-group>
                        <subject>Iron Deficiency Anemia</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Response</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Response</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Immune Physiology</subject>
                      <subj-group>
                        <subject>Antigens</subject>
                        <subj-group>
                          <subject>Antigen Isotypes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune System Proteins</subject>
                      <subj-group>
                        <subject>Antigens</subject>
                        <subj-group>
                          <subject>Antigen Isotypes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune System Proteins</subject>
                      <subj-group>
                        <subject>Antigens</subject>
                        <subj-group>
                          <subject>Antigen Isotypes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>Immune System Proteins</subject>
                        <subj-group>
                          <subject>Antigens</subject>
                          <subj-group>
                            <subject>Antigen Isotypes</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Eukaryota</subject>
                      <subj-group>
                        <subject>Protozoans</subject>
                        <subj-group>
                          <subject>Parasitic Protozoans</subject>
                          <subj-group>
                            <subject>Malarial Parasites</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Immunologic Techniques</subject>
                    <subj-group>
                      <subject>Immunoassays</subject>
                      <subj-group>
                        <subject>Enzyme-Linked Immunoassays</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Nutrition</subject>
                    <subj-group>
                      <subject>Nutritional Deficiencies</subject>
                      <subj-group>
                        <subject>Iron Deficiency</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Nutrition</subject>
                    <subj-group>
                      <subject>Nutritional Deficiencies</subject>
                      <subj-group>
                        <subject>Iron Deficiency</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Hematology</subject>
                    <subj-group>
                      <subject>Anemia</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Impact of IgG response to malaria-specific antigens and immunity against malaria in pre-school children in Ghana. A cluster randomized, placebo-controlled trial</article-title>
                <alt-title alt-title-type="running-head">Effect of iron fortification on malaria specific antigen and IgG sub-types immune responses</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tchum</surname>
                    <given-names>Samuel Kofi</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5168-4762</contrib-id>
                  <name>
                    <surname>Sakyi</surname>
                    <given-names>Samuel Asamoah</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Adu</surname>
                    <given-names>Bright</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Arthur</surname>
                    <given-names>Fareed</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4800-1769</contrib-id>
                  <name>
                    <surname>Oppong</surname>
                    <given-names>Felix Boakye</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dzabeng</surname>
                    <given-names>Francis</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Amoani</surname>
                    <given-names>Benjamin</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gyan</surname>
                    <given-names>Thomas</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Poku-Asante</surname>
                    <given-names>Kwaku</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Biochemistry and Biotechnology, College of Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Kintampo Health Research Centre, Kintampo-North, Ghana</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Immunology, College of Health Sciences, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Department of Biomedical Sciences, School of Allied Sciences, University of Cape Coast, Cape Coast, Ghana</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Carvalho</surname>
                    <given-names>Luzia Helena</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Instituto Rene Rachou, BRAZIL</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>samasamoahsakyi@yahoo.co.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>20</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>16</volume>
              <issue>7</issue>
              <elocation-id>e0253544</elocation-id>
              <history>
                <date date-type="received">
                  <day>7</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>7</day>
                  <month>6</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Tchum et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Tchum et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0253544.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>Iron fortification and micronutrient initiatives, specifically, vitamin A, and zinc supplementation are the most cost-effective developmental strategies against malnutrition and health emergencies in pre-school children. Iron-deficiency among pre-school children have been documented, however, studies evaluating the impact of immunoglobulin G (IgG) isotype responses among iron-fortified pre-school children in malaria endemic communities has not been assessed. We evaluated the impact of iron fortification on the IgG responses to GLURP R0, GLURP R2 and MSP3 FVO malaria-specific antigens among pre-school children in malaria endemic areas.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>This community-based, placebo<italic toggle="yes">-</italic>controlled, double-blinded, cluster-randomized trial study was conducted in Wenchi Municipal and Tain District of Bono Region. The trial was registered at ClinicalTrials.gov-registered trial (Identifier: NCT01001871). Ethical approval was obtained and informed consent were sought from each participant parents/guardian. For the current objective, 871 children aged 6–35 months were screened, from which 435 children received semi-liquid home-made meals mixed with 12.5 mg of iron daily (intervention group), and 436 received micronutrient powder without iron (placebo group) for 5 months. Standardized clinical and epidemiological questionnaires were administered and blood samples taken to measure IgG responses to GLURP R0, GLURP R2 and MSP3 FVO recombinant antigens using the Afro Immunoassay (AIA) protocol.</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>Baseline anthropometry, malaria diagnosis, anaemia and iron status, demographic features and dietary intake were identical among the groups (<italic toggle="yes">p</italic> &gt; 0.05). After the intervention, there was no significant difference in the IgG response against GLUP R0, GLUP R2 and MSP3 FVO between the iron-containing micronutrient and placebo groups (<italic toggle="yes">p</italic> &gt; 0.05). The iron-containing micronutrient powder group who were iron-sufficient or iron replete had significantly higher IgG response to GLURP R0 and GLURP R2 compared to iron-deficient and iron-deficiency anaemia in the same group (<italic toggle="yes">p</italic> &lt; 0.05). The IgG responses to all the three malaria specific antigens were low among children without malaria episode but high among those with two and four episodes due to exposure differences.</p>
                </sec>
                <sec id="sec004">
                  <title>Conclusion</title>
                  <p>Iron fortification did not influence antibody response against endogenous malaria specific antigens among pre-school children in malaria endemic areas, however, IgG response to malaria specific antigens were high among children with sufficient iron status.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution>National Institutes of Health (NIH)</institution>
                  </funding-source>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</institution>
                  </funding-source>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution>Office of Dietary Supplements (ODS)</institution>
                  </funding-source>
                </award-group>
                <funding-statement>National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of Dietary Supplements (ODS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="4"/>
                <page-count count="13"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the manuscript and its <xref rid="pone.0253544.s002" ref-type="supplementary-material">S1 File</xref>, <xref rid="pone.0253544.s001" ref-type="supplementary-material">S1 Checklist</xref> files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the manuscript and its <xref rid="pone.0253544.s002" ref-type="supplementary-material">S1 File</xref>, <xref rid="pone.0253544.s001" ref-type="supplementary-material">S1 Checklist</xref> files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Malaria is a major cause of morbidity and mortality among pre-school children and a main contributor to anaemia [<xref rid="pone.0253544.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0253544.ref003" ref-type="bibr">3</xref>]. In 2016, malaria accounted for over 216 million cases with 0.5 million deaths, of which 91% were from Sub-Saharan Africa [<xref rid="pone.0253544.ref003" ref-type="bibr">3</xref>]. About half of the malaria mortalities occurred among African pre-school children, with almost the same population being iron deficient [<xref rid="pone.0253544.ref004" ref-type="bibr">4</xref>].</p>
              <p>Parasitized erythrocytes have numerous antigenic surface proteins that illicit antibody response [<xref rid="pone.0253544.ref005" ref-type="bibr">5</xref>–<xref rid="pone.0253544.ref007" ref-type="bibr">7</xref>]. Asexual malaria blood stage Merozoite Surface Protein (MSP) and Glutamate Rich Protein (GLURP) antigens elicit immunological response that prevent <italic toggle="yes">in vitro</italic> parasitaemia against malaria have gone through phase 1 vaccine trials and their efficacies are being tested in both phase 2 and 3 vaccine trials among pre-school children in Sub-Saharan Africa [<xref rid="pone.0253544.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0253544.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0253544.ref011" ref-type="bibr">11</xref>].</p>
              <p>Recombinant malaria antigens GLURP R0 protein containing the conserved non-repeat N-terminal region, (amino acids 25–514), GLURP R2 (amino acids 705–1178) of the carboxyl-terminal repeat region all expressed in <italic toggle="yes">Escherichia coli</italic> and the recombinant MSP-3 of the FVO strain expressed in <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> [<xref rid="pone.0253544.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0253544.ref014" ref-type="bibr">14</xref>]. GLURP R0, GLURP R2 and MSP3 FVO antigens are blood stage malaria vaccine candidates [<xref rid="pone.0253544.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0253544.ref017" ref-type="bibr">17</xref>].</p>
              <p>Recent iron supplementation strategies to prevent malaria and anaemia have only been partially effective and antibody responses to malaria specified antigens have been inconclusive, yielding conflicting results from malaria endemic and non-endemic areas [<xref rid="pone.0253544.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0253544.ref019" ref-type="bibr">19</xref>]. The effect of iron supplementation on the immunity of pre-school children remains contentious. Some studies observed that children on iron supplements are more protected against risk of malaria and anaemia whilst other studies concluded, it rather predisposes them to malaria infection [<xref rid="pone.0253544.ref020" ref-type="bibr">20</xref>].</p>
              <p>Polymorphisms in the IgG<sub>3</sub> hinge region has been known to influence antigens specific to IgG<sub>3</sub> variants that mitigate the response to malaria and indirectly prevent anaemia [<xref rid="pone.0253544.ref013" ref-type="bibr">13</xref>]. Immunological assessment among iron-deficient pre-school children have been studied by various investigators, however, studies ascertaining the effect of immunoglobulin G (IgG) isotype responses among iron-fortified pre-school children in malaria endemic communities have not been reported, particularly regarding immunity of malaria antigen candidates, iron fortification and deficiency. Specific outcomes on the acquisition of natural protection during iron intervention at infancy and early childhood is not well understood.</p>
              <p>In addition, factors modulating immune responses against malaria vaccine candidates that may help provide possible explanations to the sub-optimal efficacies observed are not well understood. The current study assessed the impact of iron-containing micronutrient powder on malaria-specific isotype antigens IgG; GLURP R0, GLURP R2 and MSP3 FVO among pre-school children.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Materials and methods</title>
              <sec id="sec007">
                <title>Study design, site and population</title>
                <p>This community-based, placebo<italic toggle="yes">-</italic>controlled, double-blinded, cluster-randomized trial study was conducted in Wenchi Municipal and Tain District of Bono Region. Ethical approval was obtained and informed consent were sought from each participant parents/guardian. For the current objective, 871 children, aged 6–35 months were screened, from which 435 children received semi-liquid home-made meals mixed with 12.5 mg of iron daily (intervention group), and 436 received micronutrient powder without iron (placebo group) for 5 months. Standardized clinical and epidemiological questionnaires were administered and blood samples taken to measure IgG responses to GLURP R0, GLURP R2 and MSP3 FVO recombinant antigens using the Afro Immunoassay (AIA) protocol. Children with extreme anaemia (haemoglobin 70.0 g / L), severe malnutrition (weight-for-length z-score -3.0), on iron supplements during the past 6 months or had any chronic disease were excluded (<xref rid="pone.0253544.g001" ref-type="fig">Fig 1</xref>).</p>
                <fig position="float" id="pone.0253544.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0253544.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Flow diagram for participants’ selection and enrollment.</title>
                  </caption>
                  <graphic xlink:href="pone.0253544.g001" position="float"/>
                </fig>
              </sec>
              <sec id="sec008">
                <title>Ethics approval, consent and recruitment of participates</title>
                <p>Ethical approval was obtained from the Kintampo Health Research Centre Institutional Ethics Committee (KHRCIEC), (KHRC/IEC/FEA/2009-2), Ghana Health Service Ethics Committee. In addition, the Food and Drug Authority of Ghana and Hospital for Sick Children Research Ethics Board (REB), Toronto, Canada (REB File No.: 1000013476) also approved the study. The trial was registered at ClinicalTrials.gov-registered trial (<ext-link xlink:href="https://clinicaltrials.gov/ct2/show/record/NCT01001871" ext-link-type="uri">https://clinicaltrials.gov/ct2/show/record/NCT01001871</ext-link>) [<xref rid="pone.0253544.ref021" ref-type="bibr">21</xref>]. The study was explained in local dialect to parents and guardians and informed consent was obtained from respective guardians before the children were enrolled as previously described [<xref rid="pone.0253544.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. Qualifying children aged 6 to 35 months were enrolled and randomized (1:1) to receive either iron-MNP or without iron (MNP-Sprinkles® Mumbai, India). A cluster consisted of one or more households in the same compound with at least one child enrolled, and a cluster randomization design was used to prevent cross contamination between the groups through food sharing, using (in-house written programme) a computer-generated model [<xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. The detailed comprehensive randomization and recruitment process has previously been reported [<xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>].</p>
              </sec>
              <sec id="sec009">
                <title>Specimen collection, processing and analysis</title>
                <p>About 500 μl of finger or heel prick blood was collected from each participants into an ethylene diamine tetra-acetic acid (EDTA) tube at baseline (BL) and endline (EL) for haematological, malaria microscopy, acute protein process, and iron biomarker analyses as previously described [<xref rid="pone.0253544.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. Briefly, at the start of the study, a malaria rapid diagnostic test (RDT) (Paracheck Pf 1 Device, Orchid Biomedical Systems, Verna, Goa, India) was used to screen the children; those who tested positive were treated for malaria, after which they were enrolled. Fifty microliters (50 μL) of the blood was used to prepare thick and thin blood smears for malaria parasitaemia and speciation. Methanol was used to fix thin blood films and the smears were stained with Giemsa for malaria microscopy investigation. Two separate microscopists read each sample slide and if the disagreement was greater than 50% between the two readers, a third microscopist was consulted. The haematology auto-analyzer (Horiba ABX Micros 60-OT-CT-OS-CS, Montpellier, France) was used to determine the full blood count (FBC) and the QuikRead 101 analyzer was used to determine C-reactive protein (CRP) (Orion Diagnostica, Espoo, Finland). A haematofluorometer was used to measure the zinc protoporphyrin (ZPP) in red blood cells (Model 206D, Aviv Biomedical Inc. Lakewood, NJ, USA). The remaining blood sample was centrifuged to obtained plasma and the following procedures used an indirect enzyme-linked immunosorbent assay (ELISA) to measure ferritin (Fn) (Spectro Ferritin S-22, Ramco Laboratories Inc. USA) and transferrin receptor (TfR) (TFC-94, Ramco Laboratories Inc. USA) levels as previously reported in details elsewhere [<xref rid="pone.0253544.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>].</p>
                <p>The IgG responses to GLURP R0, GLURP R2 and MSP3 FVO recombinant antigens was determined using indirect enzyme-linked-immunosorbent assays (ELISA) with a little modification made in the concentrations of the coating antigens and secondary / detection antibodies as previously described [<xref rid="pone.0253544.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0253544.ref023" ref-type="bibr">23</xref>]. Briefly, 100 μL of antigens was coated directly to each well in a 96-well microtiter ELISA plate (Maxisorp Nunc, Denmark) in coating buffer (plain PBS, pH 7.04) at 1.0 μg / mL for the recombinants and 5.0 μg / mL for the peptides. The coated plates were incubated overnight in a refrigerator at 2 to 8 <sup>0</sup>C. Plates were then washed four times in washing buffer (PBS with 0.1% Tween-20 and 0.5 M NaCl) with 30 seconds incubation between each wash using the Biotek ELx 405 automated ELISA plate washer (Biotek Instruments, Winooski, VT; USA). The washed plates were padded dry on a tissue paper and blocked with 200 μL blocking buffer (PBS with 5% milk powder, 0.1% Tween-20) and incubated at room temperature in a humidified chamber for 1 hour. Plates were then washed four times in washing buffer and serum samples diluted at 1:200 in serum dilution buffer (PBS with 2.5% milk powder, 0.1% Tween-20 and 0.02% Na-azide) added at 100 μL / well in duplicates.</p>
                <p>The plates with the samples were then incubated on a clinical rotator set at 200 rpm at room temperature for 2 hours in a humidified chamber after which they were washed four times in washing buffer and the appropriate secondary (detection) antibody for the specific antibody to be determined added at 100 μL / well. The plates with the conjugates were then incubated on a clinical rotator set at 200 rpm for 1 hour at room temperature in a humidified chamber after which they were washed four times in wash buffer and padded dry. The bound secondary antibody—(Peroxidase-labelled affinity purified antibody to human IgG (H+L)) was quantified by colouring with ready to use 100 μL / well of KPL ABTS Peroxidase Substrate System soln. A + soln. B in the ratio 1:1 and incubated in the dark for 30 minutes. Optical density (OD) was read at 405 nm with a reference at 620 nm in the microplate absorbance reader (DYNEX Technologies MRX Revelation Microplate Absorbance Reader, Inc. USA).</p>
              </sec>
              <sec id="sec010">
                <title>Statistical analysis</title>
                <p>The clinical and epidemiological data were entered into a Visual Fox Pro version 9.0 (Microsoft) data management programme and imported into STATA version 14.0 (Statcorp, Texas) and SigmaPlot version 11.0 for analysis. Study participants were grouped by their wealth indices into high or low socio-economic status. The distribution and comparison of proportions of the various total IgG isotype for each antigen were analyzed using the classical and nonparametric test of hypotheses. Test with <italic toggle="yes">p</italic>-values ≤ 0.05 were considered statistically significant. Kruskal-Wallis equality-of-populations rank test was used to determine whether total IgG isotype responses to the malaria antigens were associated to the risk of clinical malaria and anaemia in the cohort study.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec011">
              <title>Results</title>
              <sec id="sec012">
                <title>Demographic, clinical and socioeconomic characteristics of study participants</title>
                <p>For the current objective, 871 children, aged 6–35 months were screened, from which 435 children received semi-liquid home-made meals mixed with 12.5 mg of iron daily (intervention group), and 436 received micronutrient powder without iron (placebo group) for 5 months. At baseline, there were no significant difference in the demographic and clinical characteristics between the groups (<italic toggle="yes">p</italic> &gt; 0.05) except that the socio-economic status of household heads in the non-iron group was significantly higher than those in the iron group (<italic toggle="yes">p</italic> = 0.02)</p>
                <p>The prevalence of low economic status of household heads was significantly higher in the iron group than in the non-iron group, whereas the prevalence of high economic status of household heads was significantly higher in the non-iron group (<italic toggle="yes">p</italic> = 0.02). (<xref rid="pone.0253544.t001" ref-type="table">Table 1</xref>).</p>
                <table-wrap position="float" id="pone.0253544.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0253544.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Baseline characteristics among study participants.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0253544.t001" id="pone.0253544.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Parameters</th>
                          <th align="justify" rowspan="1" colspan="1">Iron Group (n = 435)</th>
                          <th align="left" rowspan="1" colspan="1">Non-iron Group (n = 436)</th>
                          <th align="justify" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-values</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Total clusters number</td>
                          <td align="justify" rowspan="1" colspan="1">388</td>
                          <td align="justify" rowspan="1" colspan="1">386</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Size of cluster, median (range)</td>
                          <td align="justify" rowspan="1" colspan="1">1(1–3)</td>
                          <td align="left" rowspan="1" colspan="1">1(1–3)</td>
                          <td align="justify" rowspan="1" colspan="1">0.47</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Age, mean [range], mo</td>
                          <td align="justify" rowspan="1" colspan="1">19.6 [<xref rid="pone.0253544.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0253544.ref035" ref-type="bibr">35</xref>]</td>
                          <td align="justify" rowspan="1" colspan="1">19.4 [<xref rid="pone.0253544.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0253544.ref035" ref-type="bibr">35</xref>]</td>
                          <td align="justify" rowspan="1" colspan="1">0.74</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Sex n (%)</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1">0.97</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Female</td>
                          <td align="justify" rowspan="1" colspan="1">209 (48.8)</td>
                          <td align="justify" rowspan="1" colspan="1">214 (49.1)</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Male</td>
                          <td align="justify" rowspan="1" colspan="1">226 (51.2)</td>
                          <td align="justify" rowspan="1" colspan="1">222 (50.9)</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Asymptomatic malaria parasitaemia prevalence, n (%)</td>
                          <td align="justify" rowspan="1" colspan="1">431 (27.4%)</td>
                          <td align="justify" rowspan="1" colspan="1">434 (28.3%)</td>
                          <td align="justify" rowspan="1" colspan="1">0.75</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Moderate anaemia Prevalence, n (%)</td>
                          <td align="justify" rowspan="1" colspan="1">431 (42.7%)</td>
                          <td align="justify" rowspan="1" colspan="1">434 (40.3%)</td>
                          <td align="justify" rowspan="1" colspan="1">0.47</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Parasitaemia, n, geometric mean, count/μL of blood</td>
                          <td align="justify" rowspan="1" colspan="1">130, 2906.5</td>
                          <td align="justify" rowspan="1" colspan="1">133, 2511.9</td>
                          <td align="justify" rowspan="1" colspan="1">0.88</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Household heads economic status, n (%)</td>
                          <td align="justify" rowspan="1" colspan="1">413 (100)</td>
                          <td align="justify" rowspan="1" colspan="1">423 (100)</td>
                          <td align="justify" rowspan="1" colspan="1">0.02</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">High</td>
                          <td align="justify" rowspan="1" colspan="1">116 (28.1)</td>
                          <td align="justify" rowspan="1" colspan="1">152 (35.9)</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Low</td>
                          <td align="justify" rowspan="1" colspan="1">297 (71.9)</td>
                          <td align="justify" rowspan="1" colspan="1">271 (64.1)</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p>Frequency (n), percentages (%) of participants, age in months (mo), <italic toggle="yes">p-</italic>values are calculated by the Two-sample Wilcoxon rank-sum (Mann-Whitney) and 1-sided Fisher’s exact tests.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec013">
                <title>Effects of iron fortification on malaria specific-antigens antibody responses</title>
                <p>After the micronutrient powder (MNP) intervention, the IgG responses to the three recombinant malaria-specific antigens were similar between the iron-containing MNP and placebo groups (<italic toggle="yes">p</italic> &gt; 0.05). However, the female participants in the iron group had significant higher MSP3-FVO antigens antibody responses than their male counterpart (<italic toggle="yes">p</italic> = 0.04) (<xref rid="pone.0253544.t002" ref-type="table">Table 2</xref>).</p>
                <table-wrap position="float" id="pone.0253544.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0253544.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Effect of iron fortification on malaria antigen-specific IgG responses.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0253544.t002" id="pone.0253544.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" colspan="6" style="background-color:#FFFFFF" rowspan="1">Geometric mean of IgG responses (Arbitrary units)</th>
                        </tr>
                        <tr>
                          <th align="justify" rowspan="2" colspan="1">Malaria Antigens</th>
                          <th align="center" colspan="2" style="background-color:#FFFFFF" rowspan="1">Iron group</th>
                          <th align="justify" colspan="2" style="background-color:#FFFFFF" rowspan="1">Non-iron group</th>
                          <th align="justify" rowspan="2" colspan="1"><italic toggle="yes">p</italic>-values</th>
                        </tr>
                        <tr>
                          <th align="justify" rowspan="1" colspan="1">n(GM)</th>
                          <th align="justify" rowspan="1" colspan="1">95% CI</th>
                          <th align="justify" rowspan="1" colspan="1">n(GM)</th>
                          <th align="justify" rowspan="1" colspan="1">95% CI</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold>GLURP R0</bold>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">408(741.6)</td>
                          <td align="justify" rowspan="1" colspan="1">(627.7–876.1)</td>
                          <td align="justify" rowspan="1" colspan="1">412(807.0)</td>
                          <td align="justify" rowspan="1" colspan="1">(676.6–962.6)</td>
                          <td align="justify" rowspan="1" colspan="1">0.29</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Male</td>
                          <td align="justify" rowspan="1" colspan="1">203(630.7)</td>
                          <td align="justify" rowspan="1" colspan="1">(493.0–806.8)</td>
                          <td align="justify" rowspan="1" colspan="1">212(683.9)</td>
                          <td align="justify" rowspan="1" colspan="1">(526.1–889.0)</td>
                          <td align="justify" rowspan="1" colspan="1">0.52</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Female</td>
                          <td align="justify" rowspan="1" colspan="1">205(871.3)</td>
                          <td align="justify" rowspan="1" colspan="1">(695.9–1091.0)</td>
                          <td align="justify" rowspan="1" colspan="1">200(961.7)</td>
                          <td align="justify" rowspan="1" colspan="1">(761.4–1214.7)</td>
                          <td align="justify" rowspan="1" colspan="1">0.38</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">p</italic>-values</bold>
                          </td>
                          <td align="justify" colspan="2" rowspan="1">0.12</td>
                          <td align="justify" colspan="2" rowspan="1">0.12</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold>GLURP R2</bold>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">408(347.5)</td>
                          <td align="justify" rowspan="1" colspan="1">(297.5–406.0)</td>
                          <td align="justify" rowspan="1" colspan="1">412(361.2)</td>
                          <td align="justify" rowspan="1" colspan="1">(305.5–427.0)</td>
                          <td align="justify" rowspan="1" colspan="1">0.72</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Male</td>
                          <td align="justify" rowspan="1" colspan="1">203(319.0)</td>
                          <td align="justify" rowspan="1" colspan="1">(257.1–395.7)</td>
                          <td align="justify" rowspan="1" colspan="1">212(332.0)</td>
                          <td align="justify" rowspan="1" colspan="1">(259.5–424.8)</td>
                          <td align="justify" rowspan="1" colspan="1">0.78</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Female</td>
                          <td align="justify" rowspan="1" colspan="1">205(378.1)</td>
                          <td align="justify" rowspan="1" colspan="1">(301.8–473.6)</td>
                          <td align="justify" rowspan="1" colspan="1">200(395.0)</td>
                          <td align="justify" rowspan="1" colspan="1">(314.9–495.5)</td>
                          <td align="justify" rowspan="1" colspan="1">0.87</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">p</italic>-values</bold>
                          </td>
                          <td align="justify" colspan="2" rowspan="1">0.18</td>
                          <td align="justify" colspan="2" rowspan="1">0.26</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold>MSP3 FVO</bold>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">408(750.5)</td>
                          <td align="justify" rowspan="1" colspan="1">(447.8–869.4)</td>
                          <td align="justify" rowspan="1" colspan="1">412(753.0)</td>
                          <td align="justify" rowspan="1" colspan="1">(642.3–882.7)</td>
                          <td align="justify" rowspan="1" colspan="1">0.73</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Male</td>
                          <td align="justify" rowspan="1" colspan="1">203(653.5)</td>
                          <td align="justify" rowspan="1" colspan="1">(530.6–805.0)</td>
                          <td align="justify" rowspan="1" colspan="1">212(693.2)</td>
                          <td align="justify" rowspan="1" colspan="1">(693.2–877.6)</td>
                          <td align="justify" rowspan="1" colspan="1">0.50</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">Female</td>
                          <td align="justify" rowspan="1" colspan="1">205(860.6)</td>
                          <td align="justify" rowspan="1" colspan="1">(699.2–1059.3)</td>
                          <td align="justify" rowspan="1" colspan="1">200(851.4)</td>
                          <td align="justify" rowspan="1" colspan="1">(690.5–1049.8)</td>
                          <td align="justify" rowspan="1" colspan="1">0.81</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">p</italic>-values</bold>
                          </td>
                          <td align="justify" colspan="2" rowspan="1">
                            <bold>0.04</bold>
                          </td>
                          <td align="justify" colspan="2" rowspan="1">0.33</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>n = Number of participants, 95% CI = 95% confidence interval, GM = geometric mean; Two-sample Wilcoxon rank-sum (Mann-Whitney) test for <italic toggle="yes">p</italic>-values.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec014">
                <title>Effect of malaria-antigen specific IgG responses on anaemia and iron status</title>
                <p>Iron-deficient was defined as lack iron reserves to meet functional or metabolic needs, iron-sufficient indicates excess iron reserves, iron-replete shows that enough iron reserves to meet functional or metabolic needs and finally, iron-deficiency anaemia is the final stage of iron deficiency characterized by a mean haemoglobin level below 10 g / L in preschool children [<xref rid="pone.0253544.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. At baseline, there was no significant difference in the prevalence of iron deficiency between the children in the iron and non-iron arm (44.11% versus. 45.77%) [<xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. The prevalence of endline iron deficiency was 24.5% (N = 443, 95% CI: 22.6% - 26.6%) [<xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. Overall, endline prevalence of anaemia was 58.6% (N = 1059, 95% CI: 56.3% - 60.9%) and was more prevalent in children in the non-iron group than in those who received the iron intervention (62.63% versus. 55.52%, p = 0.003). Endline prevalence of moderate and severe anaemia were 52.7% (N = 951, 95% CI: 50.3%–55.0%) and 6.0% (N = 108, 95% CI: 5.0% - 7.2%) respectively [<xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. Therefore iron fortification mitigated anaemia and improved iron status among the preschool children [<xref rid="pone.0253544.ref022" ref-type="bibr">22</xref>]. In the iron group, the iron-replete children had significantly higher GLURP R0 and R2 antigens IgG responses than the iron-deficiency anaemics (<italic toggle="yes">p</italic> &lt; 0.05) (<xref rid="pone.0253544.t003" ref-type="table">Table 3</xref>). The iron-sufficient children also had significantly higher GLURP R0 and R2 IgG responses compared to the iron-deficiency anaemics in the same group (<italic toggle="yes">p</italic> &lt; 0.05). However, in the placebo group, the levels of GLURP RO, GLURP R2 and MSP3 FVO in either the iron replete children or iron deficiency anaemia were similar (<xref rid="pone.0253544.t003" ref-type="table">Table 3</xref>).</p>
                <table-wrap position="float" id="pone.0253544.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0253544.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Malaria antigen-specific IgG responses on anaemia and iron status.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0253544.t003" id="pone.0253544.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" colspan="6" rowspan="1">IgG Responses (Arbitrary unit)</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Malaria Antigens</th>
                          <th align="center" rowspan="1" colspan="1">n(Gm)</th>
                          <th align="center" rowspan="1" colspan="1">95% CI</th>
                          <th align="center" rowspan="1" colspan="1">n(Gm)</th>
                          <th align="center" rowspan="1" colspan="1">95% CI</th>
                          <th align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-values</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" colspan="2" rowspan="1">Iron-sufficient</th>
                          <th align="center" colspan="2" rowspan="1">Iron-deficient</th>
                          <th align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R0</td>
                          <td align="center" rowspan="1" colspan="1">630(852.3)</td>
                          <td align="center" rowspan="1" colspan="1">743.0–977.7</td>
                          <td align="center" rowspan="1" colspan="1">184(544.9)</td>
                          <td align="center" rowspan="1" colspan="1">420.5–706.0</td>
                          <td align="center" rowspan="1" colspan="1">0.001</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R2</td>
                          <td align="center" rowspan="1" colspan="1">630(390.0)</td>
                          <td align="center" rowspan="1" colspan="1">344.0–442.1</td>
                          <td align="center" rowspan="1" colspan="1">184(251.5)</td>
                          <td align="center" rowspan="1" colspan="1">192.6–328.5</td>
                          <td align="center" rowspan="1" colspan="1">0.0003</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MSP3</td>
                          <td align="center" rowspan="1" colspan="1">630(784.9)</td>
                          <td align="center" rowspan="1" colspan="1">695.3–886.0</td>
                          <td align="center" rowspan="1" colspan="1">184(635.3)</td>
                          <td align="center" rowspan="1" colspan="1">500.9–805.7</td>
                          <td align="center" rowspan="1" colspan="1">0.1</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Non-iron group</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R0</td>
                          <td align="center" rowspan="1" colspan="1">300(875.4)</td>
                          <td align="center" rowspan="1" colspan="1">713.0–1074.8</td>
                          <td align="center" rowspan="1" colspan="1">110(625.4)</td>
                          <td align="center" rowspan="1" colspan="1">441.8–885.4</td>
                          <td align="center" rowspan="1" colspan="1">0.08</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R2</td>
                          <td align="center" rowspan="1" colspan="1">300(389.5)</td>
                          <td align="center" rowspan="1" colspan="1">321.6–471.8</td>
                          <td align="center" rowspan="1" colspan="1">110(290.9)</td>
                          <td align="center" rowspan="1" colspan="1">205.6–411.7</td>
                          <td align="center" rowspan="1" colspan="1">0.06</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MSP3</td>
                          <td align="center" rowspan="1" colspan="1">300(802.6)</td>
                          <td align="center" rowspan="1" colspan="1">670.4–960.7</td>
                          <td align="center" rowspan="1" colspan="1">110(649.1)</td>
                          <td align="center" rowspan="1" colspan="1">236.8–2571.7</td>
                          <td align="center" rowspan="1" colspan="1">0.29</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Iron group</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R0</td>
                          <td align="center" rowspan="1" colspan="1">330(856.9)</td>
                          <td align="center" rowspan="1" colspan="1">277.9–3225.3</td>
                          <td align="center" rowspan="1" colspan="1">74(399.2)</td>
                          <td align="center" rowspan="1" colspan="1">104.4–1378.1</td>
                          <td align="center" rowspan="1" colspan="1">0.002</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R2</td>
                          <td align="center" rowspan="1" colspan="1">330(356.7)</td>
                          <td align="center" rowspan="1" colspan="1">135.6–1067.5</td>
                          <td align="center" rowspan="1" colspan="1">74(125.9)</td>
                          <td align="center" rowspan="1" colspan="1">54.6–730.6</td>
                          <td align="center" rowspan="1" colspan="1">0.0005</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MSP3</td>
                          <td align="center" rowspan="1" colspan="1">330(838.2)</td>
                          <td align="center" rowspan="1" colspan="1">347.2–2032.6</td>
                          <td align="center" rowspan="1" colspan="1">74(626.7)</td>
                          <td align="center" rowspan="1" colspan="1">272.1–1578.3</td>
                          <td align="center" rowspan="1" colspan="1">0.17</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" colspan="2" rowspan="1">
                            <bold>Iron-replete</bold>
                          </td>
                          <td align="center" colspan="2" rowspan="1">
                            <bold>Iron-deficient anaemia</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R0</td>
                          <td align="center" rowspan="1" colspan="1">705(806.5)</td>
                          <td align="center" rowspan="1" colspan="1">707.1–919.8</td>
                          <td align="center" rowspan="1" colspan="1">109(574.5)</td>
                          <td align="center" rowspan="1" colspan="1">416.8–791.7</td>
                          <td align="center" rowspan="1" colspan="1">0.03</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R2</td>
                          <td align="center" rowspan="1" colspan="1">705(373.5)</td>
                          <td align="center" rowspan="1" colspan="1">330.4–422.1</td>
                          <td align="center" rowspan="1" colspan="1">109(245.7)</td>
                          <td align="center" rowspan="1" colspan="1">177.9–339.3</td>
                          <td align="center" rowspan="1" colspan="1">0.01</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MSP3</td>
                          <td align="center" rowspan="1" colspan="1">705(753.0)</td>
                          <td align="center" rowspan="1" colspan="1">670.3–845.9</td>
                          <td align="center" rowspan="1" colspan="1">109(718.1)</td>
                          <td align="center" rowspan="1" colspan="1">535.0–963.9</td>
                          <td align="center" rowspan="1" colspan="1">0.73</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Non-iron Group</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R0</td>
                          <td align="center" rowspan="1" colspan="1">344(831.7)</td>
                          <td align="center" rowspan="1" colspan="1">684.7–1010.3</td>
                          <td align="center" rowspan="1" colspan="1">66(652.8)</td>
                          <td align="center" rowspan="1" colspan="1">426.2–999.9</td>
                          <td align="center" rowspan="1" colspan="1">0.19</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R2</td>
                          <td align="center" rowspan="1" colspan="1">344(377.0)</td>
                          <td align="center" rowspan="1" colspan="1">313.1–453.8</td>
                          <td align="center" rowspan="1" colspan="1">66(283.9)</td>
                          <td align="center" rowspan="1" colspan="1">190.4–423.3</td>
                          <td align="center" rowspan="1" colspan="1">0.25</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MSP3</td>
                          <td align="center" rowspan="1" colspan="1">344(773.5)</td>
                          <td align="center" rowspan="1" colspan="1">651.0–919.0</td>
                          <td align="center" rowspan="1" colspan="1">66(682.6)</td>
                          <td align="center" rowspan="1" colspan="1">454.4–1025.6</td>
                          <td align="center" rowspan="1" colspan="1">0.55</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Iron Group</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R0</td>
                          <td align="center" rowspan="1" colspan="1">361(783.1)</td>
                          <td align="center" rowspan="1" colspan="1">655.1–936.1</td>
                          <td align="center" rowspan="1" colspan="1">43(472.1)</td>
                          <td align="center" rowspan="1" colspan="1">286.9–776.9</td>
                          <td align="center" rowspan="1" colspan="1">0.06</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GLURP R2</td>
                          <td align="center" rowspan="1" colspan="1">361(370.2)</td>
                          <td align="center" rowspan="1" colspan="1">314.8–435.3</td>
                          <td align="center" rowspan="1" colspan="1">43(196.7)</td>
                          <td align="center" rowspan="1" colspan="1">112.8–343.1</td>
                          <td align="center" rowspan="1" colspan="1">0.01</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MSP3</td>
                          <td align="center" rowspan="1" colspan="1">361(734.0)</td>
                          <td align="center" rowspan="1" colspan="1">626.8–859.6</td>
                          <td align="center" rowspan="1" colspan="1">43(776.1)</td>
                          <td align="center" rowspan="1" colspan="1">506.2–1189.9</td>
                          <td align="center" rowspan="1" colspan="1">0.9</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>n = Number of participants, 95% CI = 95% confidence interval, GM = geometric mean,. Two-sample Wilcoxon rank-sum (Mann-Whitney) and Kruskal-wallis rank tests for <italic toggle="yes">p</italic>-values.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec015">
                <title>Effect of malaria-antigens specific IgG responses on malaria</title>
                <p>In iron group, the MSP3 FVO antigen IgG responses among the iron malarious children were significantly higher compared to their healthy counterparts (<italic toggle="yes">p</italic> = 0.05) (<xref rid="pone.0253544.t004" ref-type="table">Table 4</xref>). However, in both groups, the malaria-specific antigens IgG responses to GLURP RO and GLURP R2 in either the malarious or healthy participants were similar (<italic toggle="yes">p</italic> &gt; 0.05) (<xref rid="pone.0253544.t004" ref-type="table">Table 4</xref>). In both the intervention and placebo groups, the IgG responses to GLURP R0 and GLURP R2 antigens were significantly higher in the malarious children relative to the healthy group (<italic toggle="yes">p</italic> &lt; 0.05). In both groups, there was a significant rise in malaria specific-antigens IgG levels from episode zero to two (<italic toggle="yes">p</italic> &lt; 0.05) but reduces at episode three and rose again from episodes four or more (<xref rid="pone.0253544.g002" ref-type="fig">Fig 2</xref>). When there was no malaria episode, IgG levels to all three antigens were the lowest, but they were the highest for episodes two and four (<xref rid="pone.0253544.g002" ref-type="fig">Fig 2</xref>).</p>
                <fig position="float" id="pone.0253544.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0253544.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Antigen-specific IgG responses on the number of malaria episodes.</title>
                  </caption>
                  <graphic xlink:href="pone.0253544.g002" position="float"/>
                </fig>
                <table-wrap position="float" id="pone.0253544.t004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0253544.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Antigen-specific IgG responses between malaria and healthy participant.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0253544.t004" id="pone.0253544.t004g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" colspan="6" rowspan="1">IgG Responses (Arbitrary units)</th>
                        </tr>
                        <tr>
                          <th align="justify" rowspan="2" colspan="1">Malaria Antigens</th>
                          <th align="justify" colspan="2" rowspan="1">Malaria</th>
                          <th align="justify" colspan="2" rowspan="1">Healthy</th>
                          <th align="justify" rowspan="2" colspan="1"><italic toggle="yes">p</italic>-values</th>
                        </tr>
                        <tr>
                          <th align="justify" rowspan="1" colspan="1">n(GM)</th>
                          <th align="justify" rowspan="1" colspan="1">95% CI</th>
                          <th align="justify" rowspan="1" colspan="1">n(GM)</th>
                          <th align="justify" rowspan="1" colspan="1">95% CI</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">GLURP R0 (Non-iron)</td>
                          <td align="justify" rowspan="1" colspan="1">299(937.0)</td>
                          <td align="justify" rowspan="1" colspan="1">768.9–1142.0</td>
                          <td align="justify" rowspan="1" colspan="1">113(543.5)</td>
                          <td align="justify" rowspan="1" colspan="1">376.0–785.4</td>
                          <td align="justify" rowspan="1" colspan="1">0.012</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">GLURP R0 (Iron)</td>
                          <td align="justify" rowspan="1" colspan="1">294(858.6)</td>
                          <td align="justify" rowspan="1" colspan="1">705.1–1045.6</td>
                          <td align="justify" rowspan="1" colspan="1">113(506.6)</td>
                          <td align="justify" rowspan="1" colspan="1">372.9–688.2</td>
                          <td align="justify" rowspan="1" colspan="1">0.002</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">p</italic>-values</bold>
                          </td>
                          <td align="left" colspan="2" rowspan="1">0.49</td>
                          <td align="justify" colspan="2" rowspan="1">0.48</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">GLURP R2 (Non-iron)</td>
                          <td align="justify" rowspan="1" colspan="1">297(405.7)</td>
                          <td align="justify" rowspan="1" colspan="1">333.2–494.1</td>
                          <td align="justify" rowspan="1" colspan="1">113(266.1)</td>
                          <td align="justify" rowspan="1" colspan="1">194.2–364.7</td>
                          <td align="justify" rowspan="1" colspan="1">0.023</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">GLURP R2 (Iron)</td>
                          <td align="justify" rowspan="1" colspan="1">292(380.7)</td>
                          <td align="justify" rowspan="1" colspan="1">318.0–455.9</td>
                          <td align="justify" rowspan="1" colspan="1">114(275.2)</td>
                          <td align="justify" rowspan="1" colspan="1">202.4–374.0</td>
                          <td align="justify" rowspan="1" colspan="1">0.04</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">p</italic>-values</bold>
                          </td>
                          <td align="justify" colspan="2" rowspan="1">0.57</td>
                          <td align="justify" colspan="2" rowspan="1">0.71</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">MSP3 FVO (Non-iron)</td>
                          <td align="justify" rowspan="1" colspan="1">298(829.2)</td>
                          <td align="justify" rowspan="1" colspan="1">688.7–998.3</td>
                          <td align="justify" rowspan="1" colspan="1">113(620.7)</td>
                          <td align="justify" rowspan="1" colspan="1">458.7–840.0</td>
                          <td align="justify" rowspan="1" colspan="1">0.11</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">MSP3 FVO (Iron)</td>
                          <td align="justify" rowspan="1" colspan="1">294(800.3)</td>
                          <td align="justify" rowspan="1" colspan="1">666.7–961.0</td>
                          <td align="justify" rowspan="1" colspan="1">114(635.8)</td>
                          <td align="justify" rowspan="1" colspan="1">501.8–805.5</td>
                          <td align="justify" rowspan="1" colspan="1">0.05</td>
                        </tr>
                        <tr>
                          <td align="justify" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">p</italic>-values</bold>
                          </td>
                          <td align="justify" colspan="2" rowspan="1">0.83</td>
                          <td align="justify" colspan="2" rowspan="1">0.82</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p>n = Number of participants, 95% CI = 95% confidence interval, GM = geometric mean; Two-sample Wilcoxon rank-sum (Mann-Whitney) test for <italic toggle="yes">p</italic>-values.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec016">
              <title>Discussions</title>
              <p>This study for the first time assessed the impact of iron fortification on IgG responses to GLURP R0, GLURP R2 and MSP3 FVO recombinant antigens among pre-school children in malarial endemic settings. The current study found that, iron fortification did not influence IgG response to GLUP R0, GLUP R2 and MSP3 FVO. Moreover, iron fortified children with good iron status (iron replete and iron sufficient) had higher IgG response against malaria specific antigens compared to those with poor iron status (iron deficient and iron deficiency anaemics).</p>
              <p>Our findings is similar to studies by Priyanka and colleagues who conducted a randomized iron supplement controlled trial among Malawian children which compared prenatal and postnatal supplementation with multiple micronutrients, lipid-based nutrient supplementation, and observed that there iron supplementation has no effect on malaria antibody acquisition during infancy [<xref rid="pone.0253544.ref024" ref-type="bibr">24</xref>]. Likewise, other iron supplementation studies did not find significant improvement on the parameters of immunity between the intervention group and the controlled group [<xref rid="pone.0253544.ref025" ref-type="bibr">25</xref>–<xref rid="pone.0253544.ref027" ref-type="bibr">27</xref>].</p>
              <p>Our study, further observed that the female participants were more protected from malaria due to differences in certain unknown exposures compared to their male counterparts irrespective of the study group but immunity was more significant among females with IgG responses against MSP3 FVO antigens compared to the males in the iron group. This observation was consistent with a study conducted in Malawi [<xref rid="pone.0253544.ref028" ref-type="bibr">28</xref>]. On the contrary, Kaddumukasa and colleagues reported that gender was not significantly associated with increase IgG response against GLURP, HRPII and MSP3 antigens in Uganda [<xref rid="pone.0253544.ref029" ref-type="bibr">29</xref>].</p>
              <p>Research findings in recent past have indicated the important role iron plays in the immunological developments in children especially, during proliferation and maturation of immunized cells [<xref rid="pone.0253544.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0253544.ref031" ref-type="bibr">31</xref>].</p>
              <p>In our study, the immunity against the malaria antigens waned as anaemia worsen among the children and even though appreciable IgG responses were observed in the iron group, the difference between the study groups were not significant.</p>
              <p>The effect of anaemia severity on immunity clearly showed a major influence on humoral mediated immunity in our study, but knowledge on its mechanisms remain a mystery. Other studies have indicated that reduced levels of malaria-specific antibodies in iron-deficient children may indicate a decline in acquiring malaria immunity and/or a reduction in malaria exposure [<xref rid="pone.0253544.ref032" ref-type="bibr">32</xref>]. Though, the high burden of iron deficiency in African children is exacerbated by asymptomatic and febrile malaria [<xref rid="pone.0253544.ref033" ref-type="bibr">33</xref>]. Other findings, indicate that iron deficiency was related to immunity from mild clinical malaria among pre-school children [<xref rid="pone.0253544.ref034" ref-type="bibr">34</xref>]. Iron deficient and iron-deficient anaemic children in our study had lower immune response for MSP3 FVO antigen compared to the iron-sufficient and iron-replete study participants after receiving MNP with iron. Other findings suggested that humoral and cell-mediated immunogenic mechanisms were influenced by iron deficiency and iron deficiency anaemia resulting in their poor immunological response [<xref rid="pone.0253544.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0253544.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0253544.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0253544.ref037" ref-type="bibr">37</xref>]. Possibly, the effects of Iron deficient and iron-deficient anaemia in children led to impairment on the maturation and proliferation of immune cells especially B and T-lymphocytes, thus increasing their vulnerability to other infections including malaria [<xref rid="pone.0253544.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0253544.ref038" ref-type="bibr">38</xref>].</p>
              <p>We found that the iron-fortified children were more protected from malaria if they experienced two or more malaria episodes compared to children receiving MNP without iron. This findings corroborate with Tarun and Sachdev, who conducted systemic reviews of 28 randomized controlled trials involving 7892 children who were either receiving iron fortificants or placebo and concluded that there was no apparent detrimental effect on the general incidence of infection, especially malaria among the children, except a slight risk to diarrhea [<xref rid="pone.0253544.ref020" ref-type="bibr">20</xref>]. Similarly, Das and his colleagues also reported that iron supplementation improved immunity against malaria among children as their immunoglobulin responses increased in the iron group [<xref rid="pone.0253544.ref027" ref-type="bibr">27</xref>].</p>
              <p>However, in our study, we observed that IgG response induced by the malaria antigens among healthy (non-malaria) children were lower compared to malaria parasitaemic participants in the presence of iron-fortified micronutrient powder. Thereby, suggesting that iron intervention may have played a significant role in controlling parasitaemia via inhibition of the growth or invasion of malaria parasites. Consequently, it is believed that IgG antibodies that prevent blood stage malaria parasites replication are mediated by naturally adapted and induced artificial immunity in children [<xref rid="pone.0253544.ref039" ref-type="bibr">39</xref>]. Furthermore, we found that children who had malaria in the iron-fortified group had higher immune response for MSP FVO than their healthy counterparts whilst immune response to MSP FVO in the placebo did not differ between the two. This finding was in accordance with a clinical trial by Mariama et al, in Burkina Faso, who found IgG immune response to MSP3 were associated with low incidence of malaria [<xref rid="pone.0253544.ref040" ref-type="bibr">40</xref>]. However, in both groups, our study found immune response to GLURP R0 and GLURP R2 to be similar between healthy children and those with malaria. This similarity may arise from previous exposures of the control group to malaria parasites prior to this study as these children live in malaria endemic villages.</p>
              <p>Our study observed progressive protection from malaria as the number of clinical malaria episodes increased among the children in the iron group compared to children from non-iron group. Reasons for these findings maybe that, the mechanisms required to offer immunity against severe ailments are different from those that provide protection against mild diseases or infections with moderate episodes [<xref rid="pone.0253544.ref041" ref-type="bibr">41</xref>–<xref rid="pone.0253544.ref043" ref-type="bibr">43</xref>]. The main limitation of the current study was loss of children to follow-ups and inability to monitor coinfection during the follow-up.</p>
            </sec>
            <sec sec-type="conclusions" id="sec017">
              <title>Conclusion</title>
              <p>Iron fortification had no impact on IgG response to GLURP R0, GLURP R2 and MSP3 FVO malaria antigens, however, IgG response to malaria specific antigens were high among children with sufficient iron status.</p>
            </sec>
            <sec id="sec018" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0253544.s001" position="float" content-type="local-data">
                <label>S1 Checklist</label>
                <caption>
                  <title>Clinical trial check list.</title>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0253544.s001.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0253544.s002" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <title>Research study plan.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0253544.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We would like to thank the study participants, their or legal guardians; the KHRC field team and staff; chiefs, opinion leaders, and elders of participating communities; participating health facilities; the Ghana Health Service staff in Wenchi and Tain; the Ethics Boards of KHRC, Ghana Health Service, Hospital for Sick Children, and Food and Drugs Board of Ghana; and the DSMB.</p>
            </ack>
            <glossary>
              <title>List of abbreviations</title>
              <def-list>
                <def-item>
                  <term>GLURP R0</term>
                  <def>
                    <p>Glutamine Rich Protein R0</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GLURP R2</term>
                  <def>
                    <p>Glutamine Rich Protein R2</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MSP3 FVO</term>
                  <def>
                    <p>Merozoite Surface Protein (FVO)</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MNP</term>
                  <def>
                    <p>Micronutrient Powder</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IgG</term>
                  <def>
                    <p>Immunoglobulin G</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="pone.0253544.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>SC</given-names></name>, <name><surname>Breman</surname><given-names>JG</given-names></name>. <article-title>Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy</article-title>. <source>The American journal of tropical medicine and hygiene</source>. <year>2001</year>;<volume>64</volume>(<issue>1 suppl</issue>):<fpage>57</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">11425178</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Kyu</surname><given-names>HH</given-names></name>, <name><surname>Pinho</surname><given-names>C</given-names></name>, <name><surname>Wagner</surname><given-names>JA</given-names></name>, <name><surname>Brown</surname><given-names>JC</given-names></name>, <name><surname>Bertozzi-Villa</surname><given-names>A</given-names></name>, <name><surname>Charlson</surname><given-names>FJ</given-names></name>, <etal>et al</etal>. <article-title>Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study</article-title>. <source>JAMA pediatrics</source>. <year>2016</year>;<volume>170</volume>(<issue>3</issue>):<fpage>267</fpage>–<lpage>87</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.4276</pub-id>
<?supplied-pmid 26810619?><pub-id pub-id-type="pmid">26810619</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref003">
                <label>3</label>
                <mixed-citation publication-type="other">WHO. World Malaria Report 2017. World Health Organization (WHO). 2017.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref004">
                <label>4</label>
                <mixed-citation publication-type="other">WHO. World Malaria Report 2015. World Health Organization (WHO). 2015.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Faith H. A.</surname><given-names>Osier</given-names></name>, <name><surname>G. F, Spencer D.</surname><given-names>Polley</given-names></name>, <name><surname>Linda Murungi</surname></name>, <name><surname>Federica Verra</surname></name>, <name><surname>Kevin K. A.</surname><given-names>Tetteh</given-names></name>, <etal>et al</etal>. <article-title>Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria</article-title>. <source>INFECTION AND IMMUNITY</source>. <year>2008</year>;<volume>76</volume>, <issue>2008</issue>:<fpage>2240</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.01585-07</pub-id>
<?supplied-pmid 18316390?><pub-id pub-id-type="pmid">18316390</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Dodoo</surname><given-names>D</given-names></name>, <name><surname>Aikins</surname><given-names>A</given-names></name>, <name><surname>Kusi</surname><given-names>KA</given-names></name>, <name><surname>Lamptey</surname><given-names>H</given-names></name>, <name><surname>Remarque</surname><given-names>E</given-names></name>, <name><surname>Milligan</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children</article-title>. <source>Malaria journal</source>. <year>2008</year>;<volume>7</volume>(<issue>1</issue>):<fpage>142</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1475-2875-7-142</pub-id><?supplied-pmid 18664257?><pub-id pub-id-type="pmid">18664257</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>David Courtin</surname><given-names>MO</given-names></name>, <name><surname>Harm</surname><given-names>Huismans</given-names></name>, <name><surname>Kwadwo</surname><given-names>Kusi</given-names></name>, <name><surname>Jacqueline</surname><given-names>Milet</given-names></name>, <name><surname>Cyril</surname><given-names>Badaut</given-names></name>, <name><surname>Oumar</surname><given-names>Gaye</given-names></name>, <etal>et al</etal>. <article-title>Remarque, Robert Sauerwein, André Garcia, Adrian J. F. Luty. The quantity and quality of African children’s IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria</article-title>. <source>PLoS ONE</source>. <year>2009</year>;<volume>4</volume>(<issue>10</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0007590</pub-id><?supplied-pmid 19859562?><pub-id pub-id-type="pmid">19859562</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Dodoo</surname><given-names>D</given-names></name>, <name><surname>Theisen</surname><given-names>M</given-names></name>, <name><surname>Kurtzhals</surname><given-names>JA</given-names></name>, <name><surname>Akanmori</surname><given-names>BD</given-names></name>, <name><surname>Koram</surname><given-names>KA</given-names></name>, <name><surname>Jepsen</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria</article-title>. <source>Journal of Infectious Diseases</source>. <year>2000</year>;<volume>181</volume>(<issue>3</issue>):<fpage>1202</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1086/315341</pub-id>
<?supplied-pmid 10720556?><pub-id pub-id-type="pmid">10720556</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Oeuvray</surname><given-names>C</given-names></name>, <name><surname>Theisen</surname><given-names>M</given-names></name>, <name><surname>Rogier</surname><given-names>C</given-names></name>, <name><surname>Trape</surname><given-names>J-F</given-names></name>, <name><surname>Jepsen</surname><given-names>S</given-names></name>, <name><surname>Druilhe</surname><given-names>P</given-names></name>. <article-title>Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal</article-title>. <source>Infection and immunity</source>. <year>2000</year>;<volume>68</volume>(<issue>5</issue>):<fpage>2617</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.68.5.2617-2620.2000</pub-id>
<?supplied-pmid 10768952?><pub-id pub-id-type="pmid">10768952</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Soe</surname><given-names>S</given-names></name>, <name><surname>Theisen</surname><given-names>M</given-names></name>, <name><surname>Roussilhon</surname><given-names>C</given-names></name>, <name><surname>Druilhe</surname><given-names>P</given-names></name>. <article-title>Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein</article-title>. <source>Infection and immunity</source>. <year>2004</year>;<volume>72</volume>(<issue>1</issue>):<fpage>247</fpage>–<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.72.1.247-252.2004</pub-id>
<?supplied-pmid 14688102?><pub-id pub-id-type="pmid">14688102</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Cherif</surname><given-names>MK</given-names></name>, <name><surname>Ouédraogo</surname><given-names>O</given-names></name>, <name><surname>Sanou</surname><given-names>GS</given-names></name>, <name><surname>Diarra</surname><given-names>A</given-names></name>, <name><surname>Ouédraogo</surname><given-names>A</given-names></name>, <name><surname>Tiono</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso</article-title>. <source>BMC research notes</source>. <year>2017</year>;<volume>10</volume>(<issue>1</issue>):<fpage>472</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13104-017-2772-9</pub-id><?supplied-pmid 28886727?><pub-id pub-id-type="pmid">28886727</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref012">
                <label>12</label>
                <mixed-citation publication-type="book"><name><surname>Adu</surname><given-names>B</given-names></name>. <source>Immunological and Genetic Correlates of Immunity to Plasmodium Falciparum Malaria</source>: <publisher-name>Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology</publisher-name>, <publisher-loc>Kumasi</publisher-loc>; <year>2010</year>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref013">
                <label>13</label>
                <mixed-citation publication-type="book"><name><surname>Opoku-Mensah</surname><given-names>J</given-names></name>. <source>Maternally transferred antibody levels and IgG3 hinge region length polymorphisms in the risk of clinical malaria in infants in a birth cohort at Kintampo</source>, <publisher-loc>Ghana</publisher-loc>: <publisher-name>University of Ghana</publisher-name>; <year>2014</year>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Theisen</surname><given-names>M</given-names></name>, <name><surname>Vuust</surname><given-names>J</given-names></name>, <name><surname>Gottschau</surname><given-names>A</given-names></name>, <name><surname>Jepsen</surname><given-names>S</given-names></name>, <name><surname>Høgh</surname><given-names>B</given-names></name>. <article-title>Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli</article-title>. <source>Clinical and diagnostic laboratory immunology</source>. <year>1995</year>;<volume>2</volume>(<issue>1</issue>):<fpage>30</fpage>–<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/cdli.2.1.30-34.1995</pub-id>
<?supplied-pmid 7719909?><pub-id pub-id-type="pmid">7719909</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Theisen</surname><given-names>M</given-names></name>, <name><surname>Adu</surname><given-names>B</given-names></name>, <name><surname>Mordmüller</surname><given-names>B</given-names></name>, <name><surname>Singh</surname><given-names>S</given-names></name>. <article-title>The GMZ2 malaria vaccine: from concept to efficacy in humans</article-title>. <source>Expert review of vaccines</source>. <year>2017</year>;<volume>16</volume>(<issue>9</issue>):<fpage>907</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/14760584.2017.1355246</pub-id>
<?supplied-pmid 28699823?><pub-id pub-id-type="pmid">28699823</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Hamre</surname><given-names>KE</given-names></name>, <name><surname>Ondigo</surname><given-names>BN</given-names></name>, <name><surname>Hodges</surname><given-names>JS</given-names></name>, <name><surname>Dutta</surname><given-names>S</given-names></name>, <name><surname>Theisen</surname><given-names>M</given-names></name>, <name><surname>Ayodo</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Antibody correlates of protection from clinical Plasmodium falciparum malaria in an area of low and unstable malaria transmission</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>. <year>2020</year>;<volume>103</volume>(<issue>6</issue>):<fpage>2174</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4269/ajtmh.18-0805</pub-id>
<?supplied-pmid 33124533?><pub-id pub-id-type="pmid">33124533</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Adamou</surname><given-names>R</given-names></name>, <name><surname>Dechavanne</surname><given-names>C</given-names></name>, <name><surname>Sadissou</surname><given-names>I</given-names></name>, <name><surname>d’Almeida</surname><given-names>T</given-names></name>, <name><surname>Bouraima</surname><given-names>A</given-names></name>, <name><surname>Sonon</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort</article-title>. <source>Malaria journal</source>. <year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12936-018-2635-4</pub-id>
<?supplied-pmid 30602373?><pub-id pub-id-type="pmid">30602373</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Tielsch</surname><given-names>JM</given-names></name>, <name><surname>Khatry</surname><given-names>SK</given-names></name>, <name><surname>Stoltzfus</surname><given-names>RJ</given-names></name>, <name><surname>Katz</surname><given-names>J</given-names></name>, <name><surname>LeClerq</surname><given-names>SC</given-names></name>, <name><surname>Adhikari</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial</article-title>. <source>The lancet</source>. <year>2006</year>;<volume>367</volume>(<issue>9505</issue>):<fpage>144</fpage>–<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(06)67963-4</pub-id>
<?supplied-pmid 16413878?><pub-id pub-id-type="pmid">16413878</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Sazawal</surname><given-names>S</given-names></name>, <name><surname>Black</surname><given-names>RE</given-names></name>, <name><surname>Ramsan</surname><given-names>M</given-names></name>, <name><surname>Chwaya</surname><given-names>HM</given-names></name>, <name><surname>Stoltzfus</surname><given-names>RJ</given-names></name>, <name><surname>Dutta</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial</article-title>. <source>The Lancet</source>. <year>2006</year>;<volume>367</volume>(<issue>9505</issue>):<fpage>133</fpage>–<lpage>43</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Gera</surname><given-names>T</given-names></name>, <name><surname>Sachdev</surname><given-names>H</given-names></name>. <article-title>Effect of iron supplementation on incidence of infectious illness in children: systematic review</article-title>. <source>Bmj</source>. <year>2002</year>;<volume>325</volume>(<issue>7373</issue>):<fpage>1142</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.325.7373.1142</pub-id><?supplied-pmid 12433763?><pub-id pub-id-type="pmid">12433763</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Zlotkin</surname><given-names>S</given-names></name>, <name><surname>Newton</surname><given-names>S</given-names></name>, <name><surname>Aimone</surname><given-names>AM</given-names></name>, <name><surname>Azindow</surname><given-names>I</given-names></name>, <name><surname>Amenga-Etego</surname><given-names>S</given-names></name>, <name><surname>Tchum</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>310</volume>(<issue>9</issue>):<fpage>938</fpage>–<lpage>47</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2013.277129</pub-id>
<?supplied-pmid 24002280?><pub-id pub-id-type="pmid">24002280</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Tchum</surname><given-names>SK</given-names></name>, <name><surname>Arthur</surname><given-names>FK</given-names></name>, <name><surname>Adu</surname><given-names>B</given-names></name>, <name><surname>Sakyi</surname><given-names>SA</given-names></name>, <name><surname>Abubakar</surname><given-names>LA</given-names></name>, <name><surname>Atibilla</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana</article-title>. <source>Plos one</source>. <year>2021</year>;<volume>16</volume>(<issue>2</issue>):<fpage>e0246362</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0246362</pub-id><?supplied-pmid 33571267?><pub-id pub-id-type="pmid">33571267</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Nebie</surname><given-names>I</given-names></name>, <name><surname>Diarra</surname><given-names>A</given-names></name>, <name><surname>Ouedraogo</surname><given-names>A</given-names></name>, <name><surname>Soulama</surname><given-names>I</given-names></name>, <name><surname>Bougouma</surname><given-names>EC</given-names></name>, <name><surname>Tiono</surname><given-names>AB</given-names></name>, <etal>et al</etal>. <article-title>Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa</article-title>. <source>Infect Immun</source>. <year>2008</year>;<volume>76</volume>(<issue>2</issue>):<fpage>759</fpage>–<lpage>66</lpage>. Epub 2007/12/12. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.01147-07</pub-id> ; PubMed Central PMCID: PMC2223475.<?supplied-pmid 18070896?><pub-id pub-id-type="pmid">18070896</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Barua</surname><given-names>P</given-names></name>, <name><surname>Chandrasiri</surname><given-names>UP</given-names></name>, <name><surname>Beeson</surname><given-names>JG</given-names></name>, <name><surname>Dewey</surname><given-names>KG</given-names></name>, <name><surname>Maleta</surname><given-names>K</given-names></name>, <name><surname>Ashorn</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Effect of nutrient supplementation on the acquisition of humoral immunity to Plasmodium falciparum in young Malawian children</article-title>. <source>Malaria journal</source>. <year>2018</year>;<volume>17</volume>(<issue>1</issue>):<fpage>74</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12936-018-2224-6</pub-id><?supplied-pmid 29415730?><pub-id pub-id-type="pmid">29415730</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Thibault</surname><given-names>H</given-names></name>, <name><surname>Galan</surname><given-names>P</given-names></name>, <name><surname>Selz</surname><given-names>F</given-names></name>, <name><surname>Preziosi</surname><given-names>P</given-names></name>, <name><surname>Olivier</surname><given-names>C</given-names></name>, <name><surname>Badoual</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>The immune response in iron-deficient young children: effect of iron supplementation on cell-mediated immunity</article-title>. <source>European journal of pediatrics</source>. <year>1993</year>;<volume>152</volume>(<issue>2</issue>):<fpage>120</fpage>–<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF02072487</pub-id>
<?supplied-pmid 8444218?><pub-id pub-id-type="pmid">8444218</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Sejas</surname><given-names>E</given-names></name>, <name><surname>Kolsteren</surname><given-names>P</given-names></name>, <name><surname>Hoeree</surname><given-names>T</given-names></name>, <name><surname>Roberfroid</surname><given-names>D</given-names></name>. <article-title>Iron supplementation in previously anemic Bolivian children normalized hematologic parameters, but not immunologic parameters</article-title>. <source>Journal of tropical pediatrics</source>. <year>2008</year>;<volume>54</volume>(<issue>3</issue>):<fpage>164</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/tropej/fmm106</pub-id>
<?supplied-pmid 18211949?><pub-id pub-id-type="pmid">18211949</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Das</surname><given-names>I</given-names></name>, <name><surname>Saha</surname><given-names>K</given-names></name>, <name><surname>Mukhopadhyay</surname><given-names>D</given-names></name>, <name><surname>Roy</surname><given-names>S</given-names></name>, <name><surname>Raychaudhuri</surname><given-names>G</given-names></name>, <name><surname>Chatterjee</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Impact of iron deficiency anemia on cell-mediated and humoral immunity in children: A case control study</article-title>. <source>Journal of natural science, biology, and medicine</source>. <year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>158</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4103/0976-9668.127317</pub-id><?supplied-pmid 24678217?><pub-id pub-id-type="pmid">24678217</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Barua</surname><given-names>P</given-names></name>, <name><surname>Beeson</surname><given-names>JG</given-names></name>, <name><surname>Maleta</surname><given-names>K</given-names></name>, <name><surname>Ashorn</surname><given-names>P</given-names></name>, <name><surname>Rogerson</surname><given-names>SJJMj</given-names></name>. <source>The impact of early life exposure to Plasmodium falciparum on the development of naturally acquired immunity to malaria in young Malawian children</source>. <year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Kaddumukasa</surname><given-names>M</given-names></name>, <name><surname>Lwanira</surname><given-names>C</given-names></name>, <name><surname>Lugaajju</surname><given-names>A</given-names></name>, <name><surname>Katabira</surname><given-names>E</given-names></name>, <name><surname>Persson</surname><given-names>KE</given-names></name>, <name><surname>Wahlgren</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria</article-title>. <source>PloS one</source>. <year>2015</year>;<volume>10</volume>(<issue>4</issue>):<fpage>e0124297</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0124297</pub-id><?supplied-pmid 25906165?><pub-id pub-id-type="pmid">25906165</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Mascotti</surname><given-names>DP</given-names></name>, <name><surname>Rup</surname><given-names>D</given-names></name>, <name><surname>Thach</surname><given-names>RE</given-names></name>. <article-title>Regulation of iron metabolism: translational effects mediated by iron, heme, and cytokines</article-title>. <source>Annual review of nutrition</source>. <year>1995</year>;<volume>15</volume>(<issue>1</issue>):<fpage>239</fpage>–<lpage>61</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Hassan</surname><given-names>TH</given-names></name>, <name><surname>Badr</surname><given-names>MA</given-names></name>, <name><surname>Karam</surname><given-names>NA</given-names></name>, <name><surname>Zkaria</surname><given-names>M</given-names></name>, <name><surname>El Saadany</surname><given-names>HF</given-names></name>, <name><surname>Rahman</surname><given-names>DMA</given-names></name>, <etal>et al</etal>. <article-title>Impact of iron deficiency anemia on the function of the immune system in children</article-title>. <source>Medicine</source>. <year>2016</year>;<volume>95</volume>(<issue>47</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/MD.0000000000005395</pub-id><?supplied-pmid 27893677?><pub-id pub-id-type="pmid">27893677</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Bundi</surname><given-names>CK</given-names></name>, <name><surname>Nalwoga</surname><given-names>A</given-names></name>, <name><surname>Lubyayi</surname><given-names>L</given-names></name>, <name><surname>Muriuki</surname><given-names>JM</given-names></name>, <name><surname>Mogire</surname><given-names>RM</given-names></name>, <name><surname>Opi</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children</article-title>. <source>Clinical Infectious Diseases</source>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>SH</given-names></name>, <name><surname>Uyoga</surname><given-names>SM</given-names></name>, <name><surname>Armitage</surname><given-names>AE</given-names></name>, <name><surname>Khandwala</surname><given-names>S</given-names></name>, <name><surname>Mugyenyi</surname><given-names>CK</given-names></name>, <name><surname>Bejon</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Malaria and age variably but critically control hepcidin throughout childhood in Kenya</article-title>. <source>EBioMedicine</source>. <year>2015</year>;<volume>2</volume>(<issue>10</issue>):<fpage>1478</fpage>–<lpage>86</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.08.016</pub-id>
<?supplied-pmid 26629542?><pub-id pub-id-type="pmid">26629542</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Nyakeriga</surname><given-names>AM</given-names></name>, <name><surname>Troye-Blomberg</surname><given-names>M</given-names></name>, <name><surname>Dorfman</surname><given-names>JR</given-names></name>, <name><surname>Alexander</surname><given-names>ND</given-names></name>, <name><surname>Bäck</surname><given-names>R</given-names></name>, <name><surname>Kortok</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Iron deficiency and malaria among children living on the coast of Kenya</article-title>. <source>Journal of Infectious Diseases</source>. <year>2004</year>;<volume>190</volume>(<issue>3</issue>):<fpage>439</fpage>–<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1086/422331</pub-id>
<?supplied-pmid 15243915?><pub-id pub-id-type="pmid">15243915</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Rahmani</surname><given-names>S</given-names></name>, <name><surname>Demmouche</surname><given-names>A</given-names></name>. <article-title>Iron deficiency anemia in children and alteration of the immune system</article-title>. <source>J Nutr Food Sci</source>. <year>2014</year>;<volume>4</volume>:<fpage>333</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Frost</surname><given-names>JN</given-names></name>, <name><surname>Tan</surname><given-names>TK</given-names></name>, <name><surname>Abbas</surname><given-names>M</given-names></name>, <name><surname>Wideman</surname><given-names>SK</given-names></name>, <name><surname>Bonadonna</surname><given-names>M</given-names></name>, <name><surname>Stoffel</surname><given-names>NU</given-names></name>, <etal>et al</etal>. <article-title>Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection</article-title>. <source>Med</source>. <year>2021</year>;<volume>2</volume>(<issue>2</issue>):<fpage>164</fpage>–<lpage>79. e12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.medj.2020.10.004</pub-id>
<?supplied-pmid 33665641?><pub-id pub-id-type="pmid">33665641</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Zimmermann</surname><given-names>MB</given-names></name>. <article-title>Global look at nutritional and functional iron deficiency in infancy</article-title>. <source>Hematology 2014, the American Society of Hematology Education Program Book</source>. <year>2020</year>;<volume>2020</volume>(<issue>1</issue>):<fpage>471</fpage>–<lpage>7</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Ekiz</surname><given-names>C</given-names></name>, <name><surname>Agaoglu</surname><given-names>L</given-names></name>, <name><surname>Karakas</surname><given-names>Z</given-names></name>, <name><surname>Gurel</surname><given-names>N</given-names></name>, <name><surname>Yalcin</surname><given-names>I</given-names></name>. <article-title>The effect of iron deficiency anemia on the function of the immune system</article-title>. <source>The Hematology Journal</source>. <year>2005</year>;<volume>5</volume>(<issue>7</issue>):<fpage>579</fpage>–<lpage>83</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.thj.6200574</pub-id>
<?supplied-pmid 15692603?><pub-id pub-id-type="pmid">15692603</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Pratt-Riccio</surname><given-names>LR</given-names></name>, <name><surname>Bianco-Junior</surname><given-names>C</given-names></name>, <name><surname>Totino</surname><given-names>PRR</given-names></name>, <name><surname>Perce-Da-Silva</surname><given-names>DDS</given-names></name>, <name><surname>Silva</surname><given-names>LA</given-names></name>, <name><surname>Riccio</surname><given-names>EKP</given-names></name>, <etal>et al</etal>. <article-title>Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth</article-title>. <source>Memórias do Instituto Oswaldo Cruz</source>. <year>2011</year>;<volume>106</volume>:<fpage>34</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1590/s0074-02762011000900005</pub-id>
<?supplied-pmid 21881755?><pub-id pub-id-type="pmid">21881755</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Cherif</surname><given-names>MK</given-names></name>, <name><surname>Ouédraogo</surname><given-names>O</given-names></name>, <name><surname>Sanou</surname><given-names>GS</given-names></name>, <name><surname>Diarra</surname><given-names>A</given-names></name>, <name><surname>Ouédraogo</surname><given-names>A</given-names></name>, <name><surname>Tiono</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Antibody responses to P</article-title>. <source>falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso</source>. <year>2017</year>;<volume>10</volume>(<issue>1</issue>):<fpage>472</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0253544.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Marsh</surname><given-names>K</given-names></name>, <name><surname>Kinyanjui</surname><given-names>S</given-names></name>. <article-title>Immune effector mechanisms in malaria</article-title>. <source>Parasite immunology</source>. <year>2006</year>;<volume>28</volume>(<issue>1‐2</issue>):<fpage>51</fpage>–<lpage>60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-3024.2006.00808.x</pub-id>
<?supplied-pmid 16438676?><pub-id pub-id-type="pmid">16438676</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Schofield</surname><given-names>L</given-names></name>, <name><surname>Mueller</surname><given-names>I</given-names></name>. <article-title>Clinical immunity to malaria</article-title>. <source>Current molecular medicine</source>. <year>2006</year>;<volume>6</volume>(<issue>2</issue>):<fpage>205</fpage>–<lpage>21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/156652406776055221</pub-id>
<?supplied-pmid 16515511?><pub-id pub-id-type="pmid">16515511</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0253544.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Michon</surname><given-names>P</given-names></name>, <name><surname>Cole-Tobian</surname><given-names>JL</given-names></name>, <name><surname>Dabod</surname><given-names>E</given-names></name>, <name><surname>Schoepflin</surname><given-names>S</given-names></name>, <name><surname>Igu</surname><given-names>J</given-names></name>, <name><surname>Susapu</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The risk of malarial infections and disease in Papua New Guinean children</article-title>. <source>The American journal of tropical medicine and hygiene</source>. <year>2007</year>;<volume>76</volume>(<issue>6</issue>):<fpage>997</fpage>–<lpage>1008</lpage>. <?supplied-pmid 17556601?><pub-id pub-id-type="pmid">17556601</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
